)
)
)
Dash Bio
At Dash Bio, we're revolutionizing bioanalysis to expedite drug development. By leveraging robotics and modern software, we deliver higher-quality assays with turnaround times up to 10x faster than the industry average, scaling seamlessly from preclinical through late-stage clinical studies.
While drug discovery has been revolutionized with AI and breakthrough modalities, the development phase remains bogged down by manual, labor-intensive processes. We're changing that narrative. Our tech-first products automate critical steps, reducing costs and time to market while improving quality of results.
Meet Our Leadership Team:
Dave Johnson, CEO: Former Chief Data and AI Officer at Moderna.
Ander Tallett, COO: Led Enterprise Systems at Moderna and Resilience.
Ely Porter, CSO: Co-founder and CTO of Rootpath.
Together, we're crafting a future where bioanalysis is intuitive, data flows effortlessly, and drugs reach the market faster than ever before.
Join us on this journey. Learn more at dash.bio
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)